Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1997 Oct;16(10):767-9.
doi: 10.1007/BF01709263.

In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae

A L Barry  1 , P C Fuchs, S D Brown
Affiliations
Comparative Study

In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae

A L Barry et al. Eur J Clin Microbiol Infect Dis. 1997 Oct.

Abstract

The purpose of this study was to compare the in vitro activity of a new ketolide, HMR 3004 (RU64004), to that of three macrolides and one azalide against 608 Streptococcus pneumoniae and 202 Haemophilus influenzae. Macrolide-resistant pneumococci were susceptible to HMR 3004, even if they were resistant to clindamycin. Against Haemophilus influenzae, HMR 3004 and azithromycin were nearly identical in potency; the macrolides were 8- to 16-fold less active. HMR 3004 may be useful for treating respiratory tract infections if sufficient concentrations can be achieved at the local sites of infection.

PubMed Disclaimer

References

    1. Antimicrob Agents Chemother. 1996 Aug;40(8):1817-24 - PubMed
    1. J Antimicrob Chemother. 1997 Jul;40(1):139-40 - PubMed
    1. Antimicrob Agents Chemother. 1996 May;40(5):1208-13 - PubMed
    1. Antimicrob Agents Chemother. 1997 Feb;41(2):454-9 - PubMed
    1. Antimicrob Agents Chemother. 1991 Jul;35(7):1267-72 - PubMed

Publication types

MeSH terms

LinkOut - more resources